AGE-RELATED MACULAR DEGENERATION - CURRENT STATE OF THE PROBLEM AND PROPHYLAXIS METHODS

Wiad Lek. 2021;74(3 cz 2):767-772.

Abstract

Objective: The aim: Analyze the ophthalmic studies on diagnostics and treatment of patients with age-related macular degeneration to optimize diagnostics and management tactics.

Patients and methods: Materials and methods: The analysis of scientific papers due to age-related macular degeneration, vitamin D and its functions from scientometric databases: PubMed, Scopus, Web of Science. The methods were next: systematic approach, analysis, summarization and comparison.

Conclusion: Conclusions: Age-related macular degeneration is a chronic, progressive disease among people older than 50 years. Late diagnostics and inappropriate treatment may lead to irreversible central vision loss and social disadaptation. Modern studies on the pathogenesis and treatment of this pathology (that are due to the role of the immune system, antioxidants and microelements) demonstrate the effectiveness and prospects for further development around the world to find new ways to solve this problem.

Keywords: age-related macular degeneration; immune response; oxidative stress; vitamin D; vitamin D receptor.

MeSH terms

  • Antioxidants / therapeutic use
  • Humans
  • Macular Degeneration* / diagnosis
  • Macular Degeneration* / prevention & control
  • Middle Aged
  • Vitamin D
  • Vitamins / therapeutic use

Substances

  • Antioxidants
  • Vitamins
  • Vitamin D